In the present study, we evaluated the effects of apocynin, a potent inhibitor of NADPH oxidase with antioxidant properties, on the mechanisms of muscle atrophy induced by diabetes and concomitant hyperlipidemia. The gene discussed is FMO5; the disease is diabetes mellitus.